Biotech News
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ir.89bio.com2026-05-06 14:53 EST
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that